A Phase I, Open-Label, Dose Escalation and Dose Expansion Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Anti-Tumor Activity of PF-08052667 as a Single Agent and in Combination Therapy in Participants 18 Years of Age and Older with Bladder Cancer

Brief Summary

Type:
Other

Study Type:
Treatment

Phase:
I

ClinicalTrials.gov Identifier:
NCT07206225

Study #:
STUDY00162082

Start Date:
Mar 16, 2026

Full Details and Eligibility at clinicaltrials.gov

By taking part in a clinical trial, you have access to potentially effective treatments not available elsewhere. Additionally, you will contribute to cancer research, which can help other cancer patients in the future. Read the full details of this specific clinical trial by clicking on the link below.

ClinicalTrials.gov ID: NCT07206225

View Complete Trial Details & Eligibility at ClinicalTrials.gov